Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
31.09 CHF | -3.03% | -4.37% | +14.89% |
May. 22 | Sandoz: Marketing authorization for Wyost and Jubbonti in the EU | CF |
May. 22 | Sandoz Group Receives EU Approval for Cancer, Osteoporosis Biosimilars | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+14.89% | 15.25B | |
+15.37% | 41.97B | |
+21.63% | 22.34B | |
+16.53% | 14B | |
+49.78% | 12.06B | |
-9.86% | 6.8B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+14.55% | 5.49B | |
+4.00% | 4.62B |
- Stock Market
- Equities
- SDZ Stock
- News Sandoz Group AG
- Sandoz Group Logs Growth in Q1 Net Sales, Affirms FY24 Outlook